EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells

Katarzyna B Leszczynska, Amanda Freitas-Huhtamäki, Chinchu Jayaprakash, Monika Dzwigonska, Francisca N L Vitorino, Cynthia Horth, Kamil Wojnicki, Bartlomiej Gielniewski, Paulina Szadkowska, Beata Kaza, Javad Nazarian, Maciej K Ciolkowski und 6 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.113707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Katarzyna B Leszczynska und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology, Warsaw, Poland. Electronic address: k.leszczynska@nencki.edu.pl. Hauptthemen laut MEDLINE: Glioma, Diffuse Intrinsic Pontine Glioma, Brain Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse intrinsic pontine gliomas (DIPGs) are deadly pediatric brain tumors, non-resectable due to brainstem localization and diffusive growth. Over 80% of DIPGs harbor a mutation in histone 3 (H3.3 or H3.1) resulting in a lysine-to-methionine substitution (H3K27M). Patients with DIPG have a dismal prognosis with no effective therapy. We show that histone deacetylase (HDAC) inhibitors lead to a significant reduction in the H3.3K27M protein (up to 80%) in multiple glioma cell lines. We discover that the SB939-mediated H3.3K27M loss is partially blocked by a lysosomal inhibitor, chloroquine. The H3.3K27M loss is facilitated by co-occurrence of H2A.Z, as evidenced by the knockdown of H2A.Z isoforms. Chromatin immunoprecipitation sequencing (ChIP-seq) analysis confirms the occupancy of H3.3K27M and H2A.Z at the same SB939-inducible genes. We discover a mechanism showing that HDAC inhibition in DIPG leads to pharmacological modulation of the oncogenic H3.3K27M protein levels. These findings show the possibility of directly targeting the H3.3K27M oncohistone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaDiffuse Intrinsic Pontine GliomaBrain NeoplasmsHumansChildHistonesMutant ProteinsHistone Deacetylase Inhibitors

Stichwörter der Autor:innen

CP: CancerDIPGH2A.ZH3.3H3.3K27MHDAC inhibitorsSB939histone variantsmultiomicspediatric high-grade gliomas

Substanzen

HistonesMutant ProteinsHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology, Warsaw, Poland. Electronic address: k.leszczynska@nencki.edu.pl.
  • Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology, Warsaw, Poland.
  • Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA; Department of Pediatrics, University Children's Hospital Zürich, Zürich, Switzerland.
  • Children's Memorial Health Institute, Warsaw, Poland.

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NICHD NIH HHS
  • Foundation for Polish Science
  • National Science Centre Poland

Zitieren

APA

Leszczynska, K. B., Freitas-Huhtamäki, A., Jayaprakash, C., Dzwigonska, M., Vitorino, F. N. L., Horth, C., Wojnicki, K., Gielniewski, B., Szadkowska, P., Kaza, B., Nazarian, J., Ciolkowski, M. K., Trubicka, J., Grajkowska, W., Garcia, B. A., Majewski, J., Kaminska, B., & Mieczkowski, J. (2024). H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells. Cell Reports. https://doi.org/10.1016/j.celrep.2024.113707

Vancouver

Leszczynska KB, Freitas-Huhtamäki A, Jayaprakash C, Dzwigonska M, Vitorino FNL, Horth C, et al. H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells. Cell Reports. 2024. doi:10.1016/j.celrep.2024.113707

BibTeX
@article{Leszczynska2024,
  author = {Leszczynska, Katarzyna B and Freitas-Huhtamäki, Amanda and Jayaprakash, Chinchu and Dzwigonska, Monika and Vitorino, Francisca N L and Horth, Cynthia and Wojnicki, Kamil and Gielniewski, Bartlomiej and Szadkowska, Paulina and Kaza, Beata and Nazarian, Javad and Ciolkowski, Maciej K and Trubicka, Joanna and Grajkowska, Wieslawa and Garcia, Benjamin A and Majewski, Jacek and Kaminska, Bozena and Mieczkowski, Jakub},
  title = {H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.113707}
}
Kostenlos starten →